Status:
RECRUITING
VTE Risk Prevention System Based on Big Data Analysis and Multimodule System
Lead Sponsor:
Shengjing Hospital
Conditions:
Recruiting
Eligibility:
All Genders
10-90 years
Brief Summary
Venous thromboembolism (VTE) is one of the most common complications in perioperative period and the most common cause of postoperative death. VTE includes deep vein thrombosis (DVT) and acute pulmona...
Detailed Description
Venous thromboembolism (VTE) is one of the most common complications in perioperative period and the most common cause of postoperative death. VTE includes deep vein thrombosis (DVT) and acute pulmona...
Eligibility Criteria
Inclusion
- perioperative patients;
- Age range from 10 to 90 years old, gender unlimited;
- Sign informed consent.
Exclusion
- (1) non-operative patients; (2) have developed deep vein thrombosis and/or pulmonary embolism before surgery; (3) emergency operation patients; (4) Patients considered unsuitable for inclusion in the study.
Key Trial Info
Start Date :
April 14 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT05969951
Start Date
April 14 2021
End Date
April 1 2026
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China, 110004